We are live on ! Find out more
ETNB

89bio

Delisted

ETNB was delisted on the 29th of October, 2025.

184 hedge funds and large institutions have $1.58B invested in 89bio in 2025 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 80 increasing their positions, 56 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more repeat investments, than reductions

Existing positions increased: 80 | Existing positions reduced: 56

39% more capital invested

Capital invested by funds: $1.14B → $1.58B (+$444M)

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

4.7% more ownership

Funds ownership: 105.72%110.42% (+4.7%)

6% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 33

1% less funds holding

Funds holding: 186184 (-2)

79% less call options, than puts

Call options by funds: $3.66M | Put options by funds: $17.4M

Holders
184
Holders Change
-2
Holders Change %
-1.08%
% of All Funds
2.42%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
31
Increased
80
Reduced
56
Closed
33
Calls
$3.66M
Puts
$17.4M
Net Calls
-$13.7M
Net Calls Change
-$9.12M
Name Holding Trade Value Shares
Change
Change in
Stake
Susquehanna International Group
51
Susquehanna International Group
Pennsylvania
$3.24M +$1.34M +161,751 +96%
ACA
52
Apis Capital Advisors
New York
$3.16M +$58K +7,000 +2%
TI
53
Trexquant Investment
Connecticut
$2.76M +$1.51M +181,844 +183%
DFCM
54
Dark Forest Capital Management
Puerto Rico
$2.62M +$1.71M +205,974 +341%
Royal Bank of Canada
55
Royal Bank of Canada
Ontario, Canada
$2.56M +$1.61M +193,953 +291%
SFI
56
Susquehanna Fundamental Investments
Pennsylvania
$2.51M -$88.3K -10,670 -4%
VOYA Investment Management
57
VOYA Investment Management
Georgia
$2.5M +$1.01M +121,465 +91%
Two Sigma Investments
58
Two Sigma Investments
New York
$2.5M +$544K +65,660 +35%
EP
59
Eversept Partners
New York
$2.32M -$561K -67,741 -22%
Jennison Associates
60
Jennison Associates
New York
$2.3M +$1.94M +234,190 New
EAM
61
Exome Asset Management
New York
$2.29M -$997K -120,456 -34%
RA
62
Royce & Associates
New York
$2.22M +$66 +8 +0%
Hudson Bay Capital Management
63
Hudson Bay Capital Management
Connecticut
$2.22M -$203K -24,500 -10%
FMI
64
F/M Investments
District of Columbia
$2.14M +$24.1K +2,905 +1%
HCA
65
Harbor Capital Advisors
Illinois
$2.14M -$803K -97,020 -31%
Citigroup
66
Citigroup
New York
$2.12M +$76.1K +9,195 +4%
SCM
67
Superstring Capital Management
New York
$2.09M +$855K +103,221 +95%
HWAM
68
Hennion & Walsh Asset Management
New Jersey
$2.08M +$593K +71,649 +51%
AI
69
Atom Investors
Texas
$2.02M +$934K +112,780 +121%
SFM
70
Sphera Funds Management
Israel
$2.02M -$3.42M -412,668 -67%
NM
71
Newtyn Management
New York
$1.96M
OCM
72
Orchard Capital Management
Illinois
$1.95M -$2.2M -266,239 -57%
Swiss National Bank
73
Swiss National Bank
Switzerland
$1.92M -$85.3K -10,300 -5%
RhumbLine Advisers
74
RhumbLine Advisers
Massachusetts
$1.9M +$345K +41,680 +27%
Comerica Bank
75
Comerica Bank
Texas
$1.85M -$581K -70,120 -27%

ETNB Hedge Fund Activity: Q2 2025 in Review

184 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in 89bio (ETNB) for Q2 2025, worth a combined $1.58B — up 39% from $1.14B a quarter earlier.

Sellers outnumbered buyers: 33 funds closed out of ETNB and 31 opened new positions — a net loss of 2 holders — while 56 trimmed existing stakes and 80 added.

The largest buyer was Holocene Advisors, opening a new position worth an estimated $25.4M. The largest seller was Logos Global Management, exiting entirely with an estimated $18.2M sold.

  • 184 institutional investors held 89bio (ETNB) as of Q2 2025, down from 186 in Q1 2025.
  • Funds reported $1.58B of 89bio stock for Q2 2025, up 39% quarter-over-quarter.
  • 31 funds opened new 89bio positions in Q2 2025 and 33 closed out, a net change of -2 holders.
  • The largest 89bio buyer in Q2 2025 was Holocene Advisors, an estimated $25.4M added.
  • The largest 89bio seller in Q2 2025 was Logos Global Management, an estimated $18.2M sold.

Based on aggregated 13F filings for Q2 2025.